Show simple item record

Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: What is the Best Strategy?

dc.contributor.authorKucukyurt, S
dc.contributor.authorElverdi, Tuğrul
dc.contributor.authorEskazan, AE
dc.date.accessioned2021-03-02T18:30:01Z
dc.date.available2021-03-02T18:30:01Z
dc.identifier.citationKucukyurt S., Elverdi T., Eskazan A., "Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: What is the Best Strategy?", Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2020
dc.identifier.issn1083-8791
dc.identifier.othervv_1032021
dc.identifier.otherav_ddcc2516-63b2-45ac-a1ce-5c26f6ad6c18
dc.identifier.urihttp://hdl.handle.net/20.500.12627/5008
dc.identifier.urihttps://doi.org/10.1016/j.bbmt.2020.05.003
dc.language.isoeng
dc.titleManagement of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: What is the Best Strategy?
dc.typeMakale
dc.relation.journalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
dc.contributor.department, ,
dc.contributor.firstauthorID1447403


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record